|
NIPAL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.159500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.110200E-02 |
| Normal-vs-Stage2 |
1.136320E-03 |
| Normal-vs-Stage3 |
2.253700E-02 |
| Normal-vs-Stage4 |
2.757800E-01 |
| Stage1-vs-Stage2 |
6.818300E-03 |
| Stage1-vs-Stage3 |
2.463800E-01 |
| Stage1-vs-Stage4 |
8.537800E-01 |
| Stage2-vs-Stage3 |
4.871200E-01 |
| Stage2-vs-Stage4 |
4.114400E-01 |
| Stage3-vs-Stage4 |
6.189000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.242000E-02 |
| Normal-vs-AfricanAmerican |
3.136100E-02 |
| Normal-vs-Asian |
3.884300E-02 |
| Caucasian-vs-AfricanAmerican |
8.146800E-01 |
| Caucasian-vs-Asian |
2.143000E-01 |
| AfricanAmerican-vs-Asian |
1.277450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.297900E-03 |
| Normal-vs-Female |
5.150200E-01 |
| Male-vs-Female |
6.102300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.434200E-02 |
| Normal-vs-Extreme_Weight |
1.245600E-02 |
| Normal-vs-Obese |
3.018800E-01 |
| Normal-vs-Extreme_Obese |
8.320100E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.530600E-01 |
| Normal_Weight-vs-Obese |
3.780600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.153600E-01 |
| Extreme_Weight-vs-Obese |
1.216160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.374200E-01 |
| Obese-vs-Extreme_Obese |
4.796400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.107000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.374190E-01 |
| Normal-vs-Age(61-80Yrs) |
2.586000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.625600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.745400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.900400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.025970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.794200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.404900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.361980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.997900E-02 |
| Normal-VS-Type2 PRCC |
5.218700E-04 |
| Normal-VS-KIRP CIMP |
4.235600E-01 |
| Normal-VS-Unclassified PRCC |
5.640200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.117900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.736500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.573800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.156830E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.092100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.933200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.843920E-03 |
| Normal-vs-N1 |
4.555800E-02 |
| Normal-vs-N2 |
9.657400E-01 |
| N0-vs-N1 |
4.372200E-01 |
| N0-vs-N2 |
4.798800E-01 |
| N1-vs-N2 |
5.747400E-01 |
|
|
